Technological forecasting use of vaccine how to prevent Canine Visceral Leishmaniasis

• Autor(a) principal: Russo, Suzana Leitão
• Data de Publicação: 2012
• Outros Autores: Oliveira, Luana Brito de, Ribas, Sara Oliveira, Paixão, Ana Eleonora Almeida, Vieira Filho, Hildebrando
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFS
• Texto Completo: https://ri.ufs.br/handle/riufs/977
• topic: Leishmaniose; Leishmaniose visceral; Tecnologia; Leishmaniose visceral canina

Canine Visceral Leishmaniasis (CVL) is a disease caused by parasites, responsible for the significant increase in morbidity and mortality in the worldwide, becoming a serious public health problem. This disease affects both human and other animal species, more specifically the dog (reservoir of the disease). There are several methods of control, the vaccine is one of the most effective when used with other preventive measures. This study addressed the technological forecasting vaccine against canine visceral leishmaniasis, on the basis of national and international patents in order to characterize the research and / or studies being conducted with the use of the vaccine, especially noting an increase in deposits patent in the United States of América.O purpose of this research was to show the technological advancement of the use of the vaccine against leishmaniasis.